Cargando…
Protective effect of Bosutinib with caspase inhibitors on human K562 cells
INTRODUCTION: Cancer therapy has become increasingly focused on molecularly targeted medications. Despite the fact that multi-cytotoxic medication regimens have proven to be highly effective, many investigations in targeted treatments have focused on a single agent. The precise molecular mechanism o...
Autor principal: | Baty, Roua S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072916/ https://www.ncbi.nlm.nih.gov/pubmed/35531147 http://dx.doi.org/10.1016/j.sjbs.2021.11.068 |
Ejemplares similares
-
Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell
por: Niakani, Maryam, et al.
Publicado: (2020) -
Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M., et al.
Publicado: (2012) -
Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells
por: Zu, Yaqiong, et al.
Publicado: (2014) -
Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015) -
Liproxstatin-1 induces cell cycle arrest, apoptosis, and caspase-3/GSDME-dependent secondary pyroptosis in K562 cells
por: Dong, Hai-Qun, et al.
Publicado: (2022)